In winter 1997, at the age of 60, Harriet Latham Robinson pursued a faculty position as the chief of microbiology and immunology at the Yerkes National Primate Research Center at Emory University. She succeeded and co-founded GeoVax, a biotechnology company focused on developing an HIV-1 vaccine.
Born in 1938, Robinson attended the Girls' Latin School, where her limited science classes ignited a love for history and languages. She initially studied political science at Swarthmore College but shifted to biology after an introductory course. Robinson later earned her master's in biochemistry from MIT, completing her thesis work on how DNA produces different cell types through messenger RNA.
During her postdoctoral training at UC Berkeley, she studied the Rous sarcoma virus, linking RNA and helper viruses to tumor formation. In 1998, she became a professor at the University of Massachusetts Medical Center and then moved to Yerkes, where she tested candidate HIV vaccines. In 2001, she co-founded GeoVax, which aimed to transition DNA vaccines from the lab to clinical use. Although the HIV vaccine trials were halted, GeoVax continues to work on vaccines for Mpox, COVID-19, and Ebola, expanding into cancer treatment.
After a fulfilling career, Robinson retired and returned to Palo Alto, California, where she hopes to inspire young women to balance family and career aspirations. "I have had a wonderful life, far exceeding what I ever could have anticipated," Robinson reflects, celebrating her adventures, love, motherhood, and a fulfilling career in molecular biology.
Blogger's Review: Harriet Robinson's story exemplifies the success of a remarkable woman in the scientific field, showcasing her wisdom in balancing career and family. Her journey inspires countless women to pursue their professional dreams while cherishing the importance of family. Her contributions to research will continue to influence future medical advancements, particularly in vaccine development.